Anagrelide for the treatment of thrombocythaemia in daily clinical practice: a post-marketing observational survey on efficacy and safety performed in Germany.

Schmitz S, Stauch M, Schlag R.

Open source

DOI
10.1159/000264611
Published
2010-01-18
Container
Onkologie
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000264611,
  title = {Anagrelide for the treatment of thrombocythaemia in daily clinical practice: a post-marketing observational survey on efficacy and safety performed in Germany.},
  author = {Schmitz S and  Stauch M and  Schlag R.},
  year = {2010},
  journal = {Onkologie},
  doi = {10.1159/000264611},
  url = {https://doi.org/10.1159/000264611}
}

RIS

TY  - JOUR
TI  - Anagrelide for the treatment of thrombocythaemia in daily clinical practice: a post-marketing observational survey on efficacy and safety performed in Germany.
AU  - Schmitz S
AU  -  Stauch M
AU  -  Schlag R.
PY  - 2010
JO  - Onkologie
DO  - 10.1159/000264611
UR  - https://doi.org/10.1159/000264611
ER  - 

APA

S, S., M, S., & R., S. (2010). Anagrelide for the treatment of thrombocythaemia in daily clinical practice: a post-marketing observational survey on efficacy and safety performed in Germany.. Onkologie. https://doi.org/10.1159/000264611

Source records